Leading broker slaps a buy rating on Worleyparsons Limited shares: Should you buy?

The Worleyparsons Limited (ASX:WOR) share price has been a big mover this week after a leading broker labelled it a buy. Should you invest?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It certainly has been a great couple of days for the Worleyparsons Limited (ASX: WOR) share price.

The mining services company's shares have rallied a whopping 14% to a two-year high of $12.70 since the release of an investor presentation on Wednesday.

Although the presentation was reasonably light on detail regarding its current performance, management's belief that the energy and resources industry has reached an inflection point appears to have caught the eye of investors.

According to the presentation, Worleyparsons' customers are indicating a return to capex and opex growth. This is great news for the company and could be a sign that the cycle is turning.

Analysts at Deutsche Bank certainly appear to believe it is. A research note out of the investment bank this morning reveals that its analysts have upgraded Worleyparsons' shares from a hold rating to a buy with a $13.73 price target.

Deutsche anticipates the company delivering earnings growth of 21% per annum for the next couple of years.

Should you invest?

Conditions in the industry do look to be very promising for Worleyparsons right now. I think this could potentially make it a great option for investors looking to gain exposure to the resources sector.

However, I would suggest investors limit any investment to just a small part of their portfolio.

Should the cycle not turn as predicted, then the shares of Worleyparsons and its peers Downer EDI Limited (ASX: DOW), Matrix Composites & Engineering Limited (ASX: MCE), Neptune Marine Services Ltd (ASX: NMS), and Monadelphous Group Limited (ASX: MND) could come under significant selling pressure.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »